NCT01721161 arm group b684600aadb2d07aa6178fc493dd4db6 [clinicaltrials_resource:NCT01721161/arm-group/b684600aadb2d07aa6178fc493dd4db6]
arm group [clinicaltrials_vocabulary:arm-group]
NCT01721161 arm group b684600aadb2d07aa6178fc493dd4db6 [clinicaltrials_resource:NCT01721161/arm-group/b684600aadb2d07aa6178fc493dd4db6]
Bio2RDF identifier
NCT01721161/arm-group/b684600aadb2d07aa6178fc493dd4db6
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltri ...... 84600aadb2d07aa6178fc493dd4db6
description [clinicaltrials_vocabulary:description]
Participants will receive BIIB033 once every 4 weeks for 20 weeks (a total of 6 doses).
identifier
clinicaltrials_resource:NCT01721161/arm-group/b684600aadb2d07aa6178fc493dd4db6
title
NCT01721161 arm group b684600aadb2d07aa6178fc493dd4db6
@en
type
label
NCT01721161 arm group b684600a ...... 4600aadb2d07aa6178fc493dd4db6]
@en